Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1374)
  2. Journal Article (1150)
  3. Review (130)
  4. Editorial (65)
  5. Research Letter (36)
  6. Book Section (25)
  7. Correspondence (24)
  8. Guidelines (12)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Hematology-Oncology Fellows (2746)
  2. Department of Medicine (2703)
  3. Solid Tumor Oncology Division (2002)
  4. Hematologic Malignancies, Division of (1330)
  5. GSK Faculty (1228)
  6. Department of Pathology and Laboratory Medicine (982)

More Groups

People
  1. Michael Berger (218)
  2. Marc Ladanyi (198)
  3. Pedram Razavi (184)
  4. Michael Offin (176)
  5. Sergio Giralt (171)
  6. Maria Carlo (168)

More People

Years
  1. 2025 (206)
  2. 2024 (414)
  3. 2023 (330)
  4. 2022 (377)
  5. 2021 (339)
  6. 2020 (323)

More Years

Publications
  1. Journal of Clinical Oncology (568)
  2. Blood (299)
  3. Annals of Oncology (107)
  4. Clinical Cancer Research (102)
  5. Journal of Thoracic Oncology (96)
  6. Cancer Research (87)

More Publications

Publishers
  1. American Society of Clinical Oncology (643)
  2. Elsevier Inc. (343)
  3. American Society of Hematology (339)
  4. American Association for Cancer Research (239)
  5. Nature Publishing Group (201)
  6. Oxford University Press (157)

More Publishers

Results (2819)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identification of clonal hematopoiesis mutations in solid tumor patients undergoing unpaired commercial next-generation sequencing assays
    Meeting Abstract

    Coombs, C. C.; Gillis, N.; Bolton, K. L.; Berg, J. S.; Tan, X.; Hayward, M. C.; Patel, N. M.; Ball, M.; Balasis, M.; Mesa, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • DNA damage repair (DDR) germline mutations in patients (Pts) with urothelial carcinoma (UC)
    Meeting Abstract

    Carlo, M. I.; Vijai, J.; Mandelker, D.; Kemel, Y.; Regazzi, A. M.; Zhang, L.; Stadler, Z. K.; Walsh, M. F.; Cadoo, K. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Comprehensive detection of targetable fusions in lung adenocarcinomas by complementary targeted DNAseq and RNAseq assays
    Meeting Abstract

    Benayed, R.; Offin, M. D.; Mullaney, K. A.; Sukhadia, P.; Rios, K. M.; Desmeules, P.; Chang, J. C.; Hyman, D. M.; Berger, M. F.; Zehir, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Value-based healthcare delivery models in oncology: A systematic review
    Meeting Abstract

    Aviki, E.; Schleicher, S. M.; Mullangi, S.; Matsoukas, K.; Korenstein, D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Deleterious effect of baseline steroids on efficacy of PD-(L)1 blockade in patients with NSCLC
    Meeting Abstract

    Arbour, K. C.; Mezquita, L.; Long, N.; Rizvi, H.; Auclin, E.; Ni, A.; Bernal, G. M.; Chaft, J. E.; Ferrara, R.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • High frequency mismatch repair (MMR) pathway mutations in adrenocortical carcinoma: Indication for routine MMR-deficiency (MMR-D) testing
    Meeting Abstract

    Akala, O. O.; Kelly, V.; Strong, V. E.; Gopalan, A.; Reidy, D. L.; Raj, N. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Use of immunotherapy (IO) supplied free of charge to cancer patients
    Meeting Abstract

    Agarwal, R.; Epstein, A. S.; Saltz, L. B.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Qualitative study of cancer patients' advance care planning (ACP) values
    Meeting Abstract

    Agarwal, R.; Volandes, A. E.; Romano, D. R.; Genoff, M.; O'Reilly, E. M.; Breitbart, W.; Epstein, A. S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Microsatellite instability in prostate cancer and response to immune checkpoint blockade
    Meeting Abstract

    Abida, W.; Cheng, M. L.; Armenia, J.; Middha, S.; Autio, K. A.; Rathkopf, D. E.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; Carbone, E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    McBride, S. M.; Sherman, E. J.; Tsai, C. J.; Baxi, S. S.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D. C.; Michel, L. S.; Spielsinger, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save